Medication for Collapsing Trachea in Dogs: Drug Guide
By Dr. Zubair Khalid, DVM, MS, PhD ·

Medication for collapsing trachea in dogs is a layered, weight-based drug plan rather than a single prescription. The backbone is a cough suppressant, usually an opioid such as hydrocodone or butorphanol, supported as needed by a bronchodilator, a glucocorticoid, and a sedative or anxiolytic that reduces the excitement and exertion that trigger coughing fits. This guide explains what each drug class does, how the drugs are given, what can go wrong, and which monitoring steps keep a dog safe. It is written for owners of small-breed dogs with grade I or grade II collapse who are starting or refining medical therapy, and for owners of dogs with severe collapse who need to understand why medical therapy alone may not be enough.
This article is educational and is not a substitute for veterinary diagnosis or treatment.
At a Glance
| Item | Detail |
|---|---|
| What it is | A combination of four drug classes used to control cough, airway inflammation, bronchoconstriction, and excitement-triggered collapse episodes |
| What it treats | Clinical signs of tracheal collapse, mainly the honking cough and exercise intolerance, plus comorbid airway and heart disease |
| Who it is for | Dogs with mild to moderate (grade I to II) collapse, and dogs with severe collapse being stabilized or palliated |
| How it is given | Oral tablets, capsules, liquids, and inhaled formulations, all dosed by body weight |
| How fast it works | Antitussives act within about 30 to 60 minutes, bronchodilators and steroids take days to weeks for full effect, sedatives act within 30 to 60 minutes |
| How long it lasts | Antitussives 4 to 12 hours depending on the drug, bronchodilators 8 to 24 hours, steroids 12 to 24 hours, sedatives 4 to 12 hours |
| Prescription or over the counter | All four classes are prescription-only in the United States, and hydrocodone is a controlled substance |
What Collapsing Trachea Is and Why Drugs Help
Tracheal collapse is a structural, obstructive airway disease in which the cartilage rings of the windpipe flatten and the airway narrows, most often in middle-aged small-breed dogs [1][2]. The collapse is dynamic, meaning the airway diameter changes with the breathing cycle, and it can affect the cervical trachea, the thoracic inlet, the intrathoracic trachea, and the mainstem bronchi [2]. Chronic irritation from the collapsing airway produces mucosal inflammation, which produces more cough, which produces more irritation. Breaking that cycle is the central goal of drug therapy.
Clinical signs are usually proportional to the degree of collapse, ranging from mild airway irritation and paroxysmal coughing to respiratory distress and dyspnea [1]. The classic sign is a dry, harsh, honking cough, often triggered by drinking, excitement, pulling on a leash, or warm humid weather. Many dogs also have comorbid conditions that worsen signs, most commonly chronic bronchitis, bronchomalacia, and myxomatous mitral valve disease [3]. Identifying and treating those comorbidities is part of the drug plan, not a separate issue.
Medical management is the appropriate first step for most dogs. A survey of 180 veterinary specialists across 22 countries found that specialists most often prescribed opioid antitussives, glucocorticoids, anxiolytics, and antibiotics, and less frequently used bronchodilators and nonopioid cough medications [3]. That prescribing pattern reflects the practical reality that cough suppression and control of inflammation and excitement do most of the work in mild to moderate disease.
How the Four Drug Classes Fit Together
Each class targets a different part of the problem. Antitussives reduce the cough reflex itself. Bronchodilators open the lower airways and reduce the work of breathing. Glucocorticoids reduce airway inflammation. Sedatives and anxiolytics reduce the excitement and physical activity that provoke collapse episodes.
The classes are not interchangeable and they are not all started at once in every dog. A typical stable dog with grade I or II collapse starts on an antitussive plus a glucocorticoid, with a sedative added if excitement is a clear trigger, and a bronchodilator added if there is evidence of lower airway disease or if steroid side effects are a concern [3][4].
flowchart TD
A[Dog with honking cough] --> B[Veterinary examination]
B --> C[Confirm collapse and grade]
C --> D{Comorbid disease present}
D -->|Yes| E[Treat comorbidity]
D -->|No| F[Start antitussive]
E --> F
F --> G{Cough controlled}
G -->|No| H[Add steroid or bronchodilator]
G -->|Yes| I[Monitor and recheck]
H --> I
I --> J{Signs progress}
J -->|Yes| K[Discuss stent or surgery]
J -->|No| L[Continue medical plan]
Antitussives: The Cough Suppressant Core
Antitussives are the drugs most owners mean when they search for cough medicine for dogs with collapsed trachea. The goal is not to eliminate cough entirely but to reduce its frequency and force enough that the airway stops being reinjured by each episode. Cough suppressants are used to control signs and reduce chronic airway injury once coincident diseases have been managed [5].
Hydrocodone
Hydrocodone is an opioid antitussive that acts on cough centers in the central nervous system. It is one of the most commonly used cough suppressants in dogs with tracheal collapse, and it appears in the veterinary literature as a maintenance drug even after surgical intervention. In one reported case, a dog that had undergone tracheal resection and anastomosis after stent fracture was doing well one year later and required hydrocodone only infrequently [6]. That pattern is typical of how the drug is used: as needed for flare-ups rather than around the clock forever.
Hydrocodone is a controlled substance in the United States, which means it requires a prescription, a valid veterinarian-client-patient relationship, and in most states a written or electronically transmitted prescription with refill limits. Owners should expect to show identification at the pharmacy and should not expect refills without a recheck.
The main side effects are sedation, constipation, and reduced respiratory rate. Because hydrocodone suppresses the cough reflex, it must not be given to a dog with pneumonia or with retained airway secretions, because cough is the mechanism that clears those secretions. If a dog develops a moist or productive cough, fever, or increased respiratory effort, the antitussive should be stopped and the dog re-evaluated.
Butorphanol
Butorphanol is an opioid with antitussive and some sedative properties. It is used both as an oral cough suppressant and as an injectable drug for sedated airway examination, which is one reason specialists are comfortable with it in this population [3]. Its duration of action is shorter than hydrocodone, so it is often used for breakthrough coughing or for procedures rather than as the sole daily maintenance drug.
The same contraindication applies. Butorphanol suppresses cough and should not be used when there is pneumonia or when airway secretions need to be cleared. Sedation and reduced respiratory rate are the main monitoring concerns, and both are dose-related.
Dosing Caveats for Antitussives
Dosing must come from the drug label or a recognized veterinary formulary, and it must be calculated on the dog's current body weight. Small-breed dogs with tracheal collapse often weigh 4 to 8 kg, and a small error in a milligram-per-kilogram calculation becomes a large error in a dog that size. Never split a human combination cough product to approximate a veterinary dose, because many human products contain additional ingredients that are unsafe for dogs. Never invent a dose or scale a dose from a previous dog.
Bronchodilators: Opening the Lower Airway
Bronchodilators relax smooth muscle in the bronchi and bronchioles. They help most when there is concurrent lower airway disease such as chronic bronchitis or bronchomalacia, both of which are common in dogs with tracheal collapse [3]. They do not fix the collapsing cartilage, and they do not suppress cough directly.
Theophylline
Theophylline is a methylxanthine bronchodilator with an anti-inflammatory effect. It is attractive in dogs with tracheal collapse because it can be used when corticosteroid side effects are a concern [4]. A retrospective study of 47 small-breed dogs with tracheal collapse treated with theophylline-based therapy found that coughing scores decreased after treatment and clinical improvement was observed in 46 of 47 dogs (97.9 percent) [4]. In that study, theophylline was prescribed at 7.5 to 30 mg/kg by mouth every 12 hours, and serum concentrations were measured [4]. The final theophylline dose increased as the grade of intrathoracic collapse increased [4].
Two practical points follow from that study. First, theophylline dosing in dogs is individualized, and measuring serum concentration is a legitimate monitoring tool rather than an unusual step. Second, dogs tolerate a wider range of serum concentrations than humans, and undesirable effects in the study were uncommon [4]. Even so, theophylline can cause vomiting, diarrhea, restlessness, and increased heart rate, and those signs should be reported.
Terbutaline
Terbutaline is a beta-2 agonist bronchodilator. It is used in dogs with tracheal collapse when bronchoconstriction or lower airway collapse contributes to signs. It is generally used less often than theophylline in this population, consistent with the specialist survey finding that bronchodilators were used less frequently than antitussives, glucocorticoids, and anxiolytics [3].
A caution belongs here. Bronchodilators are not universally beneficial in airway collapse. In humans, bronchodilators may have detrimental effects in certain types of airway collapse, and the empiric use of these drugs in canine airway collapse has been questioned because clinical trials documenting efficacy are lacking [7]. That does not mean bronchodilators should never be used. It means they should be used for a defined reason, with a defined monitoring plan, and reassessed if they do not help.
Glucocorticoids: Controlling Airway Inflammation
Glucocorticoids reduce the mucosal inflammation that develops as the collapsing airway is repeatedly injured. They are among the most frequently prescribed drugs for tracheal collapse by specialists [3]. They are also the class with the most predictable long-term side effects, so the choice between systemic and inhaled routes matters.
Prednisone and Prednisolone
Prednisone is the standard systemic glucocorticoid. It is given orally, usually once daily, and the dose is tapered over time rather than held at the starting level indefinitely. The anti-inflammatory effect on the airway is real but takes days to reach full strength.
The side effects owners notice first are increased thirst, increased urination, increased appetite, and panting. Those are expected at anti-inflammatory doses and usually diminish as the dose is reduced. Less common but more serious problems with long-term use include gastrointestinal ulceration, muscle wasting, and increased susceptibility to infection. Dogs on systemic steroids should not be abruptly stopped after long-term use, because the adrenal glands need time to resume normal function.
Systemic steroids also increase the risk of urinary tract infection and can worsen heart failure signs in dogs with concurrent mitral valve disease, which is a common comorbidity in this population [3]. That interaction is one reason a full diagnostic workup, including an echocardiogram, is part of the standard approach [3].
Inhaled Fluticasone
Inhaled fluticasone delivers a glucocorticoid directly to the airway with much less systemic absorption than oral prednisone. It is given through a spacer and mask designed for dogs. The appeal is straightforward: airway inflammation is treated while the thirst, urination, appetite, and panting side effects of systemic steroids are largely avoided.
Inhaled therapy has practical limits. It requires the dog to tolerate a mask, it requires the owner to coordinate actuation with the dog's breathing, and it takes consistent daily use to work. It also does not replace systemic steroids during a severe flare. For dogs that need long-term anti-inflammatory therapy and cannot tolerate oral steroids, inhaled fluticasone is a reasonable option to discuss with a veterinarian.
Dosing Caveats for Glucocorticoids
Steroid doses must come from the label or a recognized formulary and must be calculated on current body weight. The starting dose, the taper schedule, and the decision to switch to an inhaled product are all case-specific. Owners should not adjust a steroid dose on their own, because both under-treatment and over-treatment carry real risks.
Sedatives and Tranquilizers: Reducing Trigger Events
Excitement, exertion, and anxiety are among the most reliable triggers for coughing episodes in dogs with tracheal collapse. Sedatives and anxiolytics reduce those triggers. Specialists commonly prescribe anxiolytics as part of the treatment plan [3].
Acepromazine
Acepromazine is a phenothiazine tranquilizer that produces sedation and reduces activity. It is useful for dogs whose collapse episodes are reliably triggered by excitement, visitors, or travel. It is long-acting, so it is usually given for a specific event rather than as a daily maintenance drug.
Acepromazine lowers blood pressure and can cause profound sedation in some dogs, especially small dogs and dogs that are already compromised. It should be used cautiously in dogs with cardiovascular disease, and it should not be combined with other sedatives without veterinary direction. Because it reduces activity, it can also mask a dog's ability to clear secretions, so it should not be used in a dog with pneumonia.
Trazodone
Trazodone is an antidepressant with sedative properties that is widely used in veterinary behavior and respiratory practice. It is often chosen when anxiety and night-time coughing are the main problems, because it can be given in the evening to reduce nocturnal episodes. It is generally better tolerated than acepromazine in dogs with heart disease, though it still lowers activity and can cause sedation, wobbliness, and gastrointestinal upset.
Dosing Caveats for Sedatives
Sedative doses must come from the label or a recognized formulary and must be calculated on current body weight. These drugs are commonly combined with opioids, and the combination can produce additive sedation and respiratory depression. Owners should report excessive sedation, difficulty waking the dog, or a slow respiratory rate immediately.
Drug Class Summary Table
| Drug class | Example agent | Key caveat | Monitoring parameter |
|---|---|---|---|
| Antitussive | Hydrocodone | Contraindicated with pneumonia or retained secretions, controlled substance | Cough frequency, sedation level, respiratory rate |
| Antitussive | Butorphanol | Shorter duration, same secretion contraindication | Sedation level, respiratory rate |
| Bronchodilator | Theophylline | Dose individualized, serum concentration may be measured | Cough score, vomiting, restlessness, heart rate |
| Bronchodilator | Terbutaline | Benefit not established for all collapse types | Respiratory effort, heart rate |
| Glucocorticoid | Prednisone | Taper required, side effects with long-term use | Thirst, urination, appetite, respiratory effort |
| Glucocorticoid | Inhaled fluticasone | Requires mask tolerance and consistent technique | Cough frequency, mask tolerance |
| Sedative | Acepromazine | Lowers blood pressure, avoid in cardiovascular disease | Sedation level, blood pressure, respiratory rate |
| Sedative | Trazodone | Additive sedation with opioids | Sedation level, respiratory rate |
How to Give These Medications Safely
Give every drug at the dose and interval written on the label or the prescription. Do not combine doses, do not double up after a missed dose, and do not stop a steroid abruptly. If a dose is missed, contact the prescribing veterinarian for instructions rather than guessing.
Weight-based dosing is the single most important safety rule in this drug plan. Weigh the dog at every recheck, because a small change in a 5 kg dog is a large percentage change. Use a veterinary-labeled product whenever one exists. Do not use human cough syrups, because many contain decongestants, acetaminophen, or other ingredients that are toxic to dogs.
Give antitussives and sedatives at the times that match the dog's trigger pattern. If coughing is worst at night, an evening dose may be more useful than a morning dose. If coughing is worst when guests arrive, give the sedative before the event rather than after the coughing starts.
Keep a simple log of coughing episodes, exercise tolerance, and any side effects. That log is the most useful thing an owner can bring to a recheck, because it shows whether the plan is working between visits.
Side Effects and What to Do About Them
Sedation is the most common side effect across the opioid and sedative classes. Mild drowsiness is expected. Difficulty waking the dog, unsteadiness that prevents standing, or a respiratory rate that seems slow for the dog's normal should be treated as an emergency.
Respiratory depression is the most serious side effect of the opioid and sedative classes. It is dose-related and is more likely when drugs from both classes are combined. Owners should learn their dog's normal resting respiratory rate at home and check it when the dog seems unusually quiet.
Gastrointestinal signs, including vomiting, diarrhea, and reduced appetite, are common with theophylline and can occur with steroids and trazodone. Persistent vomiting or a dog that will not eat should be seen.
Increased thirst, urination, appetite, and panting are expected with systemic steroids. They are not emergencies, but they should be mentioned at the next recheck because they guide the taper.
Behavior changes such as restlessness, agitation, or unusual vocalization can occur with theophylline and with trazodone. Report them rather than adjusting the dose at home.
Which Dogs Should Not Receive These Drugs
Cough suppressants should not be given to a dog with pneumonia or with retained airway secretions. Cough is how the airway clears material, and suppressing it in that setting can worsen the infection. This is the single most important contraindication in this drug guide.
Opioids and sedatives should be used with caution in dogs with significant respiratory compromise, because both can reduce respiratory drive. They should also be used cautiously in dogs with liver or kidney disease, since drug clearance may be reduced.
Systemic glucocorticoids should be used cautiously in dogs with heart failure, diabetes, or a history of gastrointestinal ulceration. Inhaled steroids reduce but do not eliminate systemic absorption.
Acepromazine should be used cautiously in dogs with cardiovascular disease because it lowers blood pressure. Dogs with concurrent myxomatous mitral valve disease, a common comorbidity in this population, fall into that category [3].
Any dog with a suspected foreign body, mass, or infection in the airway should be evaluated and treated for that problem before cough suppression is started.
Drug Interactions to Know
Opioids and sedatives interact additively. Combining hydrocodone or butorphanol with acepromazine or trazodone increases sedation and respiratory depression risk. That combination is sometimes appropriate, but it should be directed by a veterinarian with a clear monitoring plan.
Theophylline interacts with several drug classes and its clearance can be altered by other medications. Serum concentration monitoring exists for a reason, and it is most useful when a dog is on multiple drugs [4].
Steroids can worsen the effects of diabetes and can increase the risk of gastrointestinal ulceration when combined with nonsteroidal anti-inflammatory drugs. Owners should tell the veterinarian about every drug and supplement the dog receives, including over-the-counter products.
Antibiotics appear in specialist treatment plans for this population [3]. They are used when there is evidence of bacterial airway infection, not routinely, and they interact with other drugs in ways that depend on the specific antibiotic.
How Medical Therapy Compares With Other Options
Medical therapy is the first-line approach for most dogs with tracheal collapse, and most dogs respond well to it along with treatment of concurrent comorbidities [1]. The limitation is durability. A study comparing 84 dogs managed medically with 75 dogs treated with endoluminal stent placement found that clinical signs in the medically managed group generally improved in the short term but regressed and worsened over time [8]. Median survival time from diagnosis was 3.7 years for the medically managed group and 5.2 years for the stented group [8]. Among dogs with severe disease, median survival time was 12 days for medically managed dogs and 1,338 days for dogs that underwent stent placement [8].
Those numbers frame the decision clearly. Medical therapy is appropriate and effective for grade I and grade II collapse. For severe collapse, medical therapy is a bridge or a palliative measure, and surgical options including extraluminal prostheses and intraluminal stents become the treatments most likely to change the outcome [8][1][9]. Surgical techniques have their own complication profiles and require specialized training and experience, but they are associated with good short- and long-term outcomes in appropriately selected dogs [1].
A separate consideration is that some dogs have malformation-type collapse rather than traditional-type collapse. In the comparison study, 88 percent of dogs with malformation-type collapse underwent stent placement, compared with 35 percent of dogs with traditional-type collapse [8]. That difference reflects how the anatomy influences which dogs can be managed medically and which cannot.
Questions to Ask Your Veterinarian
Ask which grade of collapse your dog has and where it is located, because that determines whether medical therapy is likely to be enough. Ask which of the four drug classes your dog is starting and why each one was chosen. Ask what the target dose is, how it was calculated, and what the plan is if the dog does not improve. Ask what side effects should prompt a phone call and what should prompt an emergency visit. Ask how often rechecks should happen and what will be measured at each one. Ask whether any of the drugs are controlled substances and what that means for refills. Ask whether an inhaled steroid is a reasonable alternative if long-term oral steroids become a problem. Ask what the plan is if signs progress despite good medical management.
Limitations and When to Contact a Veterinarian
This article describes drug classes and the principles behind their use. It does not replace an examination, a diagnosis, or a prescription. Individual dogs need individual plans, and the right plan depends on the grade and location of collapse, the presence of comorbid disease, and the dog's response to treatment.
Contact a veterinarian promptly if coughing becomes more frequent or more severe despite treatment, if the dog develops a moist or productive cough, if the dog has a fever, if respiratory effort increases at rest, if the gums look blue or gray, if the dog collapses or faints, or if the dog cannot settle or sleep because of coughing.
Contact an emergency veterinary hospital immediately if the dog is struggling to breathe at rest, if the resting respiratory rate is clearly above the dog's normal baseline, if the dog is making a loud noise with every breath, if the dog cannot lie down comfortably, or if the dog is difficult to rouse after a sedative or opioid dose.
Contact the prescribing veterinarian before making any change to a medication, including skipping a dose, splitting a tablet, or stopping a steroid. Abrupt steroid withdrawal can cause serious illness.
Frequently Asked Questions
What is the most common medication for collapsing trachea in dogs?
Opioid antitussives such as hydrocodone and butorphanol are the most commonly used cough suppressants, and specialists most often prescribe opioid antitussives, glucocorticoids, and anxiolytics together [3].
Can I use human cough medicine for my dog with a collapsed trachea?
No. Human cough products often contain additional ingredients that are unsafe for dogs, and dosing must come from a veterinary label or formulary rather than from a human product.
Are cough suppressants always safe for a dog with a collapsed trachea?
No. Cough suppressants are contraindicated when there is pneumonia or retained airway secretions, because cough is how the airway clears material.
How is the dose of these medications determined?
Every dose is calculated on the dog's current body weight and taken from the drug label or a recognized veterinary formulary. Doses are never invented or scaled from another dog.
What side effects should I watch for?
Sedation and reduced respiratory rate are the most important, especially when an opioid and a sedative are combined. Vomiting, restlessness, and increased thirst are also common depending on the drug.
Do bronchodilators help every dog with a collapsed trachea?
No. Bronchodilators help most when there is concurrent lower airway disease, and their benefit has not been established for every type of airway collapse [7].
Is medical therapy enough for severe tracheal collapse?
Medical therapy is the first-line approach for most dogs, but signs in medically managed dogs tend to improve initially and then worsen over time, and dogs with severe disease have much better outcomes with stent placement [8].
How often should my dog be rechecked while on these medications?
Recheck timing depends on the drug plan and the dog's stability. Ask the prescribing veterinarian for a specific schedule, and bring a written log of coughing episodes and side effects to each visit.
Related Articles
- Collapsing Trachea in Toy Breeds: Cough Suppressants vs Stent Placement
- Why Is My Dog Coughing honking sound? Kennel Cough vs Collapsed Trachea
- Dog Reverse Sneeze Or Collapsed Trachea
- Pharmacotherapy in Avian Medicine
- Drug Interactions with Antihypertensive Medications in Veterinary Patients
- Can You Give Your Dog Human Cough Medicine? What Vets Say
- Dog Incontinence Drugs: Medication Options Compared
- Ranitidine in Veterinary Medicine: Uses and Dosing
Sources
- Canine tracheal collapse.
- Use of intraluminal nitinol stents in the treatment of tracheal collapse in a dog.
- Specialists' approach to tracheal collapse: survey-based opinions on diagnostics, medical management, and comorbid diseases.
- A retrospective study of theophylline-based therapy with tracheal collapse in small-breed dogs: 47 cases (2013-2017).
- Tracheal collapse. Diagnosis and medical and surgical treatment.
- Fracture of an endoluminal nitinol stent used in the treatment of tracheal collapse in a dog.
- Lower airway collapse: Revisiting the definition and clinicopathologic features of canine bronchomalacia.
- Comparison of short-, intermediate-, and long-term results between dogs with tracheal collapse that underwent multimodal medical management alone and those that underwent tracheal endoluminal stent placement.
- Long-term outcomes of 54 dogs with tracheal collapse treated with a continuous extraluminal tracheal prosthesis.